Does CAPLACIZUMAB Cause Off label use? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Off label use have been filed in association with CAPLACIZUMAB (Cablivi). This represents 17.9% of all adverse event reports for CAPLACIZUMAB.
26
Reports of Off label use with CAPLACIZUMAB
17.9%
of all CAPLACIZUMAB reports
5
Deaths
8
Hospitalizations
How Dangerous Is Off label use From CAPLACIZUMAB?
Of the 26 reports, 5 (19.2%) resulted in death, 8 (30.8%) required hospitalization, and 5 (19.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB Cause?
Condition aggravated (13)
Platelet count decreased (12)
Drug ineffective (10)
Maternal exposure during pregnancy (10)
Pyrexia (10)
Thrombotic thrombocytopenic purpura (10)
Foetal exposure during pregnancy (9)
Foetal growth restriction (9)
Haemorrhage (9)
Deep vein thrombosis (8)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CAPLACIZUMAB Alternatives Have Lower Off label use Risk?
CAPLACIZUMAB vs CAPLACIZUMAB-YHDP
CAPLACIZUMAB vs CAPMATINIB
CAPLACIZUMAB vs CAPREOMYCIN
CAPLACIZUMAB vs CAPSAICIN
CAPLACIZUMAB vs CAPTOPRIL